Bone Biologics Corporation (BBLGW)
Price:
43.49 USD
( + 7.54 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
iRhythm Technologies, Inc.
VALUE SCORE:
5
2nd position
Viemed Healthcare, Inc.
VALUE SCORE:
11
The best
TransMedics Group, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
NEWS
Bone Biologics (NASDAQ:BBLGW) Stock Price Down 0.3% – What’s Next?
defenseworld.net
2026-02-19 03:31:02Bone Biologics Co. (NASDAQ: BBLGW - Get Free Report) shares were down 0.3% during trading on Wednesday. The stock traded as low as $29.75 and last traded at $31.95. Approximately 1,309 shares were traded during mid-day trading, an increase of 77% from the average daily volume of 738 shares. The stock had previously closed at
Bone Biologics (NASDAQ:BBLGW) Trading Up 2.2% – Should You Buy?
defenseworld.net
2026-01-03 02:34:54Shares of Bone Biologics Co. (NASDAQ: BBLGW - Get Free Report) were up 2.2% during mid-day trading on Friday. The company traded as high as $16.06 and last traded at $15.50. Approximately 4 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 1,370 shares. The stock had previously
No data to display
Bone Biologics (NASDAQ:BBLGW) Stock Price Down 0.3% – What’s Next?
defenseworld.net
2026-02-19 03:31:02Bone Biologics Co. (NASDAQ: BBLGW - Get Free Report) shares were down 0.3% during trading on Wednesday. The stock traded as low as $29.75 and last traded at $31.95. Approximately 1,309 shares were traded during mid-day trading, an increase of 77% from the average daily volume of 738 shares. The stock had previously closed at
Bone Biologics (NASDAQ:BBLGW) Trading Up 2.2% – Should You Buy?
defenseworld.net
2026-01-03 02:34:54Shares of Bone Biologics Co. (NASDAQ: BBLGW - Get Free Report) were up 2.2% during mid-day trading on Friday. The company traded as high as $16.06 and last traded at $15.50. Approximately 4 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 1,370 shares. The stock had previously